WRN and cancer: Inactivation of RecQL2 (WRN), RecQL3 (BLM), and RecQL4 leads to Werner’s syndrome, Bloom syndrome and Rothmund–Thomson syndrome, respectively; these disorders are characterized by genome instability, increased cancer risk and, in the case of Werner syndrome, adult-onset premature aging [9,10,11,12].